![Prognostic impacts of glucocorticoid treatment in patients with polymyalgia rheumatica and giant cell arteritis | Scientific Reports Prognostic impacts of glucocorticoid treatment in patients with polymyalgia rheumatica and giant cell arteritis | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-85857-4/MediaObjects/41598_2021_85857_Fig1_HTML.png)
Prognostic impacts of glucocorticoid treatment in patients with polymyalgia rheumatica and giant cell arteritis | Scientific Reports
![PDF) Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: Influence of corticosteroid therapy PDF) Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: Influence of corticosteroid therapy](https://www.researchgate.net/profile/Maria-Bartolome/publication/10773923/figure/fig2/AS:601803490066434@1520492541407/Plasma-homocysteine-levels-in-A-PMR-and-B-GCA-patients-before-and-after-treatment_Q320.jpg)
PDF) Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: Influence of corticosteroid therapy
Effect of high dose intravenous ascorbic acid on the level of inflammation in patients with rheumatoid arthritis
![Polymyalgia Rheumatica and Giant Cell Arteritis. History of PMR and GCA First description: BC –Treatment was removal of affected artery English. - ppt download Polymyalgia Rheumatica and Giant Cell Arteritis. History of PMR and GCA First description: BC –Treatment was removal of affected artery English. - ppt download](https://images.slideplayer.com/30/9509325/slides/slide_11.jpg)